Report on stroke data as required by the Coverdell-Murphy Act, Georgia SB549 [Dec. 2015]

Report on Stroke Data as Required by the Coverdell-Murphy Act, Georgia SB549 Compiled by the Georgia Department of Public Health December 2015
Background
Why should we care about stroke in Georgia?
Stroke is the fourth-leading cause of death in Georgia (3,694 stroke deaths in 2013)1
Georgia's age-standardized stroke death rate in 2013 was 13.5% higher than the national average1
In 2013, Georgia had the 10th-highest stroke death rate compared to other U.S. states1
Stroke is a leading cause of disability.2 Treatment of eligible stroke patients with the drug tissue plasminogen activator (tPA) can reduce disability by 30%, but the drug needs to be administered in the first three hours after symptom onset.3
Georgians had 23,742 stroke hospitalizations in 2013 o The median cost per hospitalization was $27,077 o The total stroke-related hospitalization charges were over $1 billion in Georgia
Georgia is in the "Stroke Belt," an area in the southeastern U.S. with stroke death rates that are approximately 20% higher than the rest of the U.S. The coastal plains of Georgia are in the "buckle" of the Stroke Belt, an area with stroke death rates about 40% higher than the rest of the nation.4 o The higher death rates seen in the Stroke Belt can be collectively explained, in large part, by demographic and socioeconomic factors and the prevalence of stroke risk factors and chronic diseases like diabetes and hypertension.5
Only 43% of Georgia stroke deaths occurred in a hospital in 2013. This suggests that most stroke sufferers and witnesses are not recognizing stroke events or calling emergency services quickly enough.
More than one-fifth (21.1%) of Georgia stroke deaths were premature, i.e. among persons under the age of 65 years, based on 2013 death data.1
The stroke death rate for blacks in Georgia was 38% higher than the rate for whites in 2013.1

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

1

Adult Georgians have high prevalence rates for stroke-related risk factors. 2013 and 2014 Behavioral Risk Factors Surveillance System data showed that:6 o 35% of adult Georgians had hypertension (2013 BRFSS)
o 38% had high cholesterol (2013 BRFSS)
o 12% were diabetic (2014 BRFSS)
o 30% were obese(2014 BRFSS)
o 24% were physically inactive (2014 BRFSS)
o 17% of Georgia adults smoked (2014 BRFSS)
Coverdell-Murphy Act Required Reporting Georgia's Coverdell-Murphy Act (CMA), or Senate Bill 549, enacted in 2008, requires the reporting of specific types of stroke data to the Georgia Department of Public Health (DPH) as part of the Georgia Coverdell Acute Stroke Registry (GCASR).7 The required elements are in Table 1 in bold, exactly as specified in the law. With exceptions noted for data coming from Georgia Emergency Medical Services (EMS), all data in this report come from GCASR. GCASR currently has 69 participating acute care hospitals, of which 42 are comprehensive or primary stroke centers, and four are remote stroke treatment centers. Georgia EMS provides data on the number of subjects evaluated and transported to acute care facilities with a presumptive diagnosis of acute stroke. This report covers the years 2012 through 2014 in Georgia. Some data elements specified in the law are not available through GCASR or EMS (see Table 1) and thus are not reported here.
Summary of Data Findings According to available data, Georgians received a consistently high quality of stroke care during 2012 to 2014. The median time from hospital arrival to administration of the clotbusting drug tPA to ischemic stroke patients was shortened from 66 minutes in 2012 to 58 minutes in 2014. Numbers for many other quality indicators, such as stroke education and discharge on appropriate medication, also improved in Georgia from 2012 to 2014.
In Georgia during 2012 to 2014:
The number of patients delivered to hospitals by EMS with a presumptive stroke diagnosis, based on provider impression, increased by 37% from 2012 to 2014.
The number of Georgians receiving acute interventional therapy for stroke, defined as tPA administration, increased by 28% from 2012 to 2014.

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

2

The median door-to-needle time for tPA administration improved by 12%, decreasing from 66 minutes to 58 minutes. Door-to-needle time refers to the minutes elapsed from when the patient arrives at the hospital to the administration of tPA.
The median length of hospital stay for stroke patients remained low (3 days) from 2012 to 2014.
The percentage of eligible stroke patients who received venous thromboembolic prophylaxis remained consistently high at 95% from 2012 to 2014.
The percentage of eligible stroke patients discharged on antiplatelet or antithrombotic medications remained consistently high at 99% and 98% from 2012 to 2014..
The percentage of eligible atrial fibrillation patients who received anticoagulation therapy increased from 95% to 98% from 2012 to 2014.
The percentage of eligible patients who had antithrombotic medication administered within 48 hours of hospitalization remained consistently high at 97% from 2012 to 2014.
The number of lipid profiles ordered increased by 10% from 2012 to 2014.
The percentage of eligible patients receiving dysphagia screening remained at 87% from 2012 to 2014.
The percentage of patients who received all five components of the recommended stroke education progressively increased from 90% to 94% from 2012 to 2014.
The percentage of eligible patients receiving help for smoking cessation or with whom smoking cessation was discussed remained consistently high at 98% and 96%, respectively, from 2012 to 2014.
The percentage of eligible patients who were assessed for rehabilitation and for whom a plan for rehabilitation was considered remained consistently high at 98% from 2012 to 2014.
The number of hospital-admitted stroke patients who were transported by EMS increased by 10% from 2012 to 2014.
The percentage of eligible stroke patients treated with intravenous tPA increased from 75% to 91% from 2012 to 2014.
The percentage of eligible stroke patients who were discharged on cholesterol-reducing medication increased from 91% to 94% from 2012 to 2014.

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

3

Table 1. Coverdell-Murphy Act Required Data Elements available via GCASR or Georgia EMS, Georgia, 2012-2014

Indicator (Statewide)

2012

2013

2014

1. The number of patients evaluated Defined as the total number of incidents which were reported by dispatch or transported by EMS as stroke or transient ischemic attack Data source: Georgia EMS data
2. The number of patients receiving acute interventional therapy
Defined as number of stroke patients receiving tPA administration
3. The amount of time from patient presentation to delivery of acute interventional therapy Median door-to-needle time in minutes (Interquartile Range)
4. Patient length of hospital stay Median length of stay in days (Interquartile Range)
5. Patient functional outcome Not collected; see Table 2 for alternative data
6. Patient morbidity Not collected; see Note below
7. Deep vein thrombosis prophylaxis given Percent among eligible patients
8. Number of patients discharged on anti-platelet or antithrombotic medication Percent among eligible patients
9. Number of patients with atrial fibrillation receiving anticoagulation therapy Percent among eligible patients
10. Patients on which the administration of tissue plasminogen activator was considered Not collected; see Note below
11. Antithrombotic medication administered within 48 hours of hospitalization Percent among eligible patients

--*

12,652

10742

995

1,050

1,278

66 (50, 88)
3 (2, 6)
--
-9,623
95% 7,880
99% 921 95%
--
6,712 97%

61.5 (47, 86)

58 (43, 83)

3 (2, 7)
--
-10,319
95% 8,570
99%
1,014 96%
--

3 (2, 7)
--
-10,771
95% 8,951
98%
1,088 98%
--

7308 97%

7521 97%

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

4

Indicator (Statewide)
12. Number of lipid profiles ordered during hospitalization
13. Number of screens for dysphagia performed Percent among eligible patients
14. Stroke education provided Number of patients who received all five components of stroke education by GCASR Percent among eligible patients
15. Number of smoking cessation programs provided or discussed Percent among eligible patients
16. The number of patients assessed for rehabilitation and whether a plan for rehabilitation was considered Percent among eligible patients
17. The number of emergency medical services stroke patients who were transported to the hospital facility Defined as number of patients delivered to hospital by EMS with a presumptive stroke diagnosis based on provider impression Data source: Georgia EMS data
18. The number of emergency medical services stroke patients who were admitted to the facility
19. The number and percentage of stroke cases treated with intravenous or intra-arterial tissue plasminogen activator Percent among IV tPA eligible patients
20. The number of patients discharged on cholesterol- reducing medication Percent among eligible patients
Total Patients

2012
11,740 8,785 87%

2013
12,492 9,314 87%

2014
12,935 9,800
87%

5,447 90%
1,531 98%
9,680 98%

5,967 93%
1,626 98%
10,413 98%

6,214 94%
1,689 96%
10,846 98%

6,191

6,929

8,473

6,999
513 75%
5,853 91%
14,845

7,058
590 89%
6,501 93%
15,870

7,671
673 91%
6,769 94%
16,469

* Data not available for 2012.
Eligibility for specific care varies and is based on criteria set by the Paul Coverdell National Acute Stroke Registry for measuring the performance of hospitals in stroke patient care. The five stroke education components are: modifiable risk factors, warning signs and symptoms, activating EMS for stroke, prescribed medication, and follow-up after discharge.

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

5

Note: Some data elements listed in the Coverdell-Murphy Act are not available via GCASR or Georgia EMS (noted in Table 1) and thus are not reported here. Modification or clarification of the missing elements in the CMA may allow for future reporting on these elements. The GCASR collects some alternative data elements for "patient functional outcome" (Table 2). While these data are not exactly what the CMA stipulates, they are indeed indicators of patient outcomes.

Table 2. Additional Data from the Georgia Coverdell Acute Stroke Registry, 2011-2103

Data Element
Ambulatory status of patient at discharge, if documented
Able to ambulate independently with or without device Percent among eligible patients
Able to ambulate with assistance by another person Percent among eligible patients
Unable to ambulate Percent among eligible patients

2011

2012

2013

7,232 57%
3,527 28%
1,970 16%

7,602 59%
3,354 26%
1,889 15%

8,418 60%
3,492 25%
2,080 15%

Conclusions
The Georgia Coverdell Acute Stroke Registry is funded by the Centers for Disease Control and Prevention to improve stroke systems of care in Georgia. Participating EMS agencies, hospitals, and rehabilitation centers are working to strengthen the existing working relationship and developing new approaches in pursuit of delivering the best stroke care at all levels of the patient care continuum. Currently, GCASR- participating hospitals account for more than eighty percent of all Georgia stroke admissions. They have already had a major impact on the lives of thousands across the state by limiting the damage and disability from stroke. Analyses of hospital data indicated that ischemic stroke patients treated at GCASR facilities were less likely to die one year post-discharge than patients treated at non-GCASR facilities.8
Valid performance indicators need to be identified and applied to measure and monitor the quality of care across the continuum of stroke care. GCASR-participating hospitals are providing a quality stroke care as evidenced by the consistently high levels of performance measures. It is imperative to monitor both the pre and post-hospital stroke care. With the advent of a new five-year grant from the Centers for Disease Control and Prevention the GCASR will now emphasize adopting and implementing performance indicators to improve the quality of both pre- and post-hospital care of stroke patients.

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

6

With an aging Georgia population9 entering the stroke-prone years (above 55 years)10, the number of Georgians affected by stroke is expected to rise over the next decade, which will increase costs, both financially and in terms of productive years of life lost. We must continue to improve stroke prevention and treatment across the state by reducing the prevalence of stroke risk factors in Georgia, and increasing public awareness of stroke signs and symptoms and knowledge to call 911 immediately for stroke. We must also continue to enhance hospital-based acute treatments and post-hospital rehabilitation services, including home care. Although we've made great progress, there's a great deal more to do to address this major public health problem in Georgia.

References 1. Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying
Cause of Death 1999-2010 on CDC WONDER Online Database, released 2012. Data are from the Multiple Cause of Death Files, 1999-2010, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed at http://wonder.cdc.gov/ucd-icd10.html on Dec 4, 2014.
2. Centers for Disease Control and Prevention (CDC). Prevalence and most common causes of disability among adults: United States, 2005. MMWR Morb Mortal Wkly Rep. 2009;58:421426. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5816a2.htm
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1588. Available at: http://www.nejm.org/doi/full/10.1056/NEJM199512143332401#t=article
4. Go AS, Mozaffarian D, Roger VL, et al; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013;127:e6e245. Available at: http://circ.ahajournals.org/content/125/1/e2.full.pdf+html
5. Liao Y, Greenlund KJ, Croft JB, et al. Factors Explaining Excess Stroke Prevalence in the US Stroke Belt. Stroke, 2009, 40:3336-3341. Available at: http://stroke.ahajournals.org/content/40/10/3336.full
6. Georgia Behavioral Risk Factor Surveillance System Data 2013. Chronic Disease, Healthy Behaviors, and Injury Epidemiology, Georgia Department of Public Health. For more information: http://dph.georgia.gov/georgia-behavioral-risk-factor-surveillance-system-brfss
7. Georgia Coverdell-Murphy Act. SB 549, Section 31-11-116. 14 May 2008, Official Code of Georgia Annotated, 2008. Available at: http://www.legis.ga.gov/Legislation/20072008/85749.pdf
8. Ido MS, Bayakly R, Frankel M, Lyn R, Okosun IS. Administrative data linkage to evaluate a quality improvement program in acute stroke care, Georgia, 2006-2009. Prev Chronic Dis. 2015 Jan 15;12:E05. doi: 10.5888/pcd12.140238.
9. US Administration on Aging, Department of Health and Human Services. State Projections of Population Aged 65 and over: July 1, 2005 to 2030. Available at: http://www.aoa.gov/Aging_Statistics/future_growth/future_growth.aspx#state see StatePercent_65+yr-ageprojections-2005-2030.xls
10. Ralph L. Sacco R, Emelia J. Benjamin EJ, Joseph P. Broderick JP, Mark Dyken M, J. Donald Easton JD, William M. Feinberg WM, et. Al. Risk Factors. Stroke. 1997;28:1507-1517. Available at http://stroke.ahajournals.org/content/28/7/1507.full

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

7

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

8

Definitions: Anticoagulation, Antiplatelet, and Antithrombotic Medications: Medications that reduce blood clotting.
Deep Vein Thrombosis: When a blood clot forms in a vein deep in the body, usually in the leg. If the clot breaks off, it can cause serious complications and even death.
Door-to-Needle Time: Time elapsed in minutes from when an eligible stroke patient arrives at the hospital to when tPA is administered. Eligible patients must receive tPA within 3 hours of symptom onset.
Dysphagia Screening: Screening for difficulty in swallowing. This identifies patients who need targeted treatment to improve their ability to swallow, so they do not aspirate or take fluid into the lungs. Aspiration of fluid can lead to pneumonia.
Ischemic Stroke: A stroke caused by a clot or blockage in a blood vessel supplying blood to the brain. The majority of strokes in Georgia are ischemic.
Hemorrhagic Stroke: A stroke caused by a blood vessel rupturing and bleeding in the brain. Hemorrhagic strokes are often fatal.
Lipid Profile: Panel of tests to measure cholesterol and triglyceride levels. High cholesterol is a risk factor for stroke.
Tissue Plasminogen Activator (tPA): FDA-approved clot-busting drug for stroke. This drug can reduce disability by 30% in stroke sufferers if given to eligible patients within 3 hours of symptom onset.

Know the Signs and Symptoms of Heart Attack and Stroke

Heart attack and stroke are life-threatening emergencies. Call 911 if you experience these symptoms.

Signs of Heart Attack Chest discomfort. Most heart attacks involve
discomfort in the center of the chest that lasts more than a few minutes, or that goes away and comes back. It can feel like uncomfortable pressure, squeezing, fullness, or pain. Discomfort in other areas of the upper body. Symptoms can include pain or discomfort in one or both arms, the back, neck, jaw, or stomach. Shortness of breath. This feeling often accompanies chest discomfort. But it can occur before the chest discomfort. Other symptoms may include nausea, lightheadedness, or breaking out in a cold sweat.

Signs of Stroke Sudden numbness or weakness of the face, arm, or leg, especially on one side of the body. Sudden confusion, trouble speaking or understanding. Sudden trouble seeing in one or both eyes Sudden trouble walking, dizziness, loss of balance or coordination. Sudden, severe headache with no known cause.

2015 Report on Stroke Data Required by the Coverdell-Murphy Act

9